← Leaderboards
Peter Silvera
Advanced Bioscience Laboratories, Inc.
$18,392,128
Attributed
$18,392,128
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $5.6M · FY2020–25$10M$7.5M$5M$2.5M$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$18,392,128 · 3
By mechanism
N01$18,392,128 · 3
Top collaborators
No co-investigators on record.
Most similar at Advanced Bioscience Laboratories, Inc.
Same institution · by research overlap
- Maria Grazia Ferrari$2,400,205
- Ranajit Pal$45,474,422
- Glen Swartz$1,137,319
- Glenn Swartz$1,044,520
- Maria Grazia Ferrari$734,396
Others in their field
Other Emerging Leaders on “National Institute Of Allergy And Infectious Disease”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Beth Baseler · Leidos Biomedical Research, Inc.$158,999,256
- Kimberly Smith · Ppd Development Lp$122,921,392
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Marlene Ann Cooper · Harvard University D/B/A Harvard School Of Public Health$72,037,072
- Ted Ross · University Of Georgia$71,962,304
Research focus
National Institute Of Allergy And Infectious DiseasePreventionResourcesPre-ClinicalAids PreventionResearch Clinical TestingContractsPrevention StrategyInvestigator-Initiated ResearchTechnologyResearch StudyMicrobicidePreventServicesProduct DevelopmentPre-Exposure ProphylaxisPlayClinical TrialsAcquired Immunodeficiency SyndromePreventive VaccineCollaborationsLicensureAnti-Hiv MicrobicideHiv Infections
Grant awards (46)
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery$1,272,115
N01 · FY2025 · AI · contact PI
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels$814,149
N01 · FY2025 · AI · contact PI
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support$551,408
N01 · FY2025 · AI · contact PI
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services$66,177
N01 · FY2025 · AI · contact PI
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Blocker Discovery$1,324,494
N01 · FY2024 · AI · contact PI
Use of Artificial Intelligence/Machine Learning (AI/ML) to Enhance the STEP Pediatric Excipient Database$1,193,090
N01 · FY2024 · AI · contact PI
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels$807,060
N01 · FY2024 · AI · contact PI
Expertise in Professional Pharmaceutical Project Management$693,109
N01 · FY2024 · AI · contact PI
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support$534,007
N01 · FY2024 · AI · contact PI
Expertise in Development of Pediatric Drug Formulations$487,868
N01 · FY2024 · AI · contact PI
Participation in a Workshop on Development of Animal Models Supporting Pediatric Formulation Development$253,411
N01 · FY2024 · AI · contact PI
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques$89,310
N01 · FY2024 · AI · contact PI
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge$85,597
N01 · FY2024 · AI · contact PI
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services$63,592
N01 · FY2024 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)$23,892
N01 · FY2024 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding$987,196
N01 · FY2023 · AI · contact PI
Resource to Advance Pediatrics and HIV Prevention Science (RAPPS): Quality Assurance/Quality Control (QA/QC) Support$517,164
N01 · FY2023 · AI · contact PI
Expertise in Development of Pediatric Drug Formulations$408,668
N01 · FY2023 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Material Receipt, Storage, Shipping and Inventory$65,610
N01 · FY2023 · AI · contact PI
Resources to Advance Pediatrics and HIV Prevention Science: Scientific and Quality/Regulatory Support Services$61,114
N01 · FY2023 · AI · contact PI
Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques$1,473
N01 · FY2023 · AI · contact PI
Support for Enhancing Study Drug Adherence in HIV Prevention Trials$940
N01 · FY2023 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: NHP Purchase and Holding$970,160
N01 · FY2022 · AI · contact PI
Characterization of the Pharmacokinetic/Pharmacodynamic (PK/PD) Profile of a Candidate HIV Prevention Drug in Rhesus Macaques$968,613
N01 · FY2022 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Quality Assurance/ Quality Control (QA/QC)$527,994
N01 · FY2022 · AI · contact PI
Characterization of Drug Substances in a Dual Indication Vaginal Ring for Prevention of HIV and Pregnancy$455,080
N01 · FY2022 · AI · contact PI
Statistical and Pharmacometric Modeling Support for HIV Non-Vaccine Biomedical Prevention Product Development$276,444
N01 · FY2022 · AI · contact PI
Expertise in Development of Pediatric Drug Formulations$258,221
N01 · FY2022 · AI · contact PI
Support for Enhancing Study Drug Adherence in HIV Prevention Trials$157,753
N01 · FY2022 · AI · contact PI
Ethnographic Expertise for Enhancing Study Drug Adherence in HIV Prevention Trials$149,812
N01 · FY2022 · AI · contact PI
Advancing the Development of Pediatric Drug Formulations: Planning and Implementation of a DAIDS-Industry Pediatric Formulation Partnership and Pediatric Drug Formulation Think Tank$137,941
N01 · FY2022 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Material Receipt, Storage, Shipping and Inventory$105,730
N01 · FY2022 · AI · contact PI
Expansion and Characterization of Relevant Simian Immunodeficiency Virus (SIV) Stocks for Use in Drug Assays or Repeat, Low-Dose Challenge Studies in Rhesus Macaques$83,598
N01 · FY2022 · AI · contact PI
Comprehensive Resources for HIV Microbicides and Biomedical Prevention: Scientific and Quality/Regulatory Support Services$82,905
N01 · FY2022 · AI · contact PI
SVEU - Core Activities - Administrative and Technical Support$35,416
N01 · FY2022 · AI · contact PI
Simian Vaccine Evaluation Units - Maintenance of Nonhuman Primates$29,383
N01 · FY2022 · AI · contact PI
SVEU - Final Transition and Continued Operation of the Nonhuman Primate Breeding Colony During Transition$838,085
N01 · FY2021 · AI · contact PI
SVEU - Core Activities - Administrative and Technical Support$257,128
N01 · FY2021 · AI · contact PI
Expertise in Development of Pediatric Drug Formulations$210,503
N01 · FY2021 · AI · contact PI
Comparison of Bivalent vs Pentavalent Subtype C Envelope HIV-1 Vaccine Efficacy Following Mucosal Virus Challenge$56,656
N01 · FY2021 · AI · contact PI
SVEU - Operation of a NHP Breeding Colony$1,414,508
N01 · FY2020 · AI · contact PI
Quality Evaluation and ISO Biocompatibility Studies Supporting a Cabotegravir Implant for HIV Prevention$506,161
N01 · FY2020 · AI · contact PI
SVEU - Core Activities - Administrative and Technical Support$248,647
N01 · FY2020 · AI · contact PI
Expertise in Development of Pediatric Drug Formulations$207,305
N01 · FY2020 · AI · contact PI
Advancing the Development of Pediatric Drug Formulations: Planning and Implementation of a DAIDS-Industry Pediatric Formulation Partnership and Pediatric Drug Formulation Think Tank$101,909
N01 · FY2020 · AI · contact PI
SVEU - MAINTENANCE OF NONHUMAN PRIMATES$10,732
N01 · FY2020 · AI · contact PI